“I believe in many settings, liquid biopsy Guardant360-based test results are more reliable than tissue-based testing,” said Dr. Balazs Halmos, Director of Thoracic Oncology and Professor of Medicine at Montefiore Health System.

Another medical oncologist from New York, Dr. Nicholas Rohs from Mount Sinai Medical Center said, “Over the past couple of years, we have generated a lot of data that shows us that this concordance rate between tissue and liquid changes the paradigm, it makes us know that tissue is not the gold standard in a way.”

Click on the video below to find out why these two medical oncologists believe that liquid biopsies like Guardant360® are quickly changing the face of precision oncology. Visit us online @ guardanthealthamea.com to find out more about Guardant360®, the global leader in liquid biopsy. If you have any queries, send us an email at [email protected] or contact us on WhatsApp: +65 8940 0360.

Guardant360®. Test. Take Action.